000 | 01080 a2200277 4500 | ||
---|---|---|---|
005 | 20250517211237.0 | ||
264 | 0 | _c20190207 | |
008 | 201902s 0 0 eng d | ||
022 | _a1532-2149 | ||
024 | 7 |
_a10.1002/ejp.1229 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBäckryd, E | |
245 | 0 | 0 |
_aDo the potential benefits outweigh the risks? An update on the use of ziconotide in clinical practice. _h[electronic resource] |
260 |
_bEuropean journal of pain (London, England) _c08 2018 |
||
300 |
_a1193-1202 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAnalgesics, Non-Narcotic _xtherapeutic use |
650 | 0 | 4 |
_aChronic Pain _xdrug therapy |
650 | 0 | 4 | _aEurope |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPractice Patterns, Physicians' |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 |
_aomega-Conotoxins _xtherapeutic use |
773 | 0 |
_tEuropean journal of pain (London, England) _gvol. 22 _gno. 7 _gp. 1193-1202 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/ejp.1229 _zAvailable from publisher's website |
999 |
_c28268147 _d28268147 |